CARE — Financials Setup
CARE is showing elite fundamentals with 900% EPS growth and 260% revenue growth, backed by a 41.8% net margin. The technical setup confirms Stage 2 with all trend criteria passing and relative strength ranking 87 versus SPY—this is a high-quality candidate. A cheat entry is valid here with price just 0.3% above MA20 and RSI constructive at 56.5. Risk to your calculated stop is 3.0%, which is tight but manageable. No earnings within 10 days removes that variable. The R:R to 52W high is 2.8:1, meeting minimum standards. Confirm the trade is working if price holds above MA20 and closes with volume supporting the move. The setup breaks if price closes below your $30.95 stop—this is Base 3, so watch for early fatigue. Best entry window is 10:00-10:30 AM after opening volatility settles, confirming price is holding near MA20 before entering.
Close below $30.95
Yes. The original thesis played out substantially as written. The thesis identified CARE as a Stage 2 setup with elite fundamentals and a tight base near MA20, projected a 2.8:1 risk-to-reward ratio to the 52-week high, and flagged the key confirmation condition—price holding above MA20 on volume. The trade was exited at target after a 6.24% gain over 14 days with the stop never tested, and the thesis's prescribed exit condition (target reached) was met. No material claims in the frozen thesis were contradicted by market action.
The scanner's assessment of setup quality proved reliable. Price entered just 0.3% above MA20 as predicted, remained constructive above the moving average throughout the hold, and advanced to target within the projected timeframe. The fundamental inputs—particularly the combination of extreme earnings growth and revenue expansion paired with strong net margins—correlated with a stock that exhibited low-volatility upside momentum. The rubric's Stage 2 classification was validated; the trade showed textbook behavior of an early-stage advance without false breaks or violent reversals.
The thesis achieved its minimum objective but may have exited prematurely relative to the setup's potential. At the target price of $33.90, the stock held above MA20 and had not yet shown any sign of fatigue or breakdown. The original thesis noted that Base 3 structures warrant watching for "early fatigue," but no fatigue markers were recorded or appear to have been observed before the exit signal fired. Additionally, no record was kept of the actual volume behavior or close-to-close confirmation that the thesis listed as a key monitoring condition, meaning the quality of the exit decision cannot be fully evaluated.
| Rubric Section | Signal | Assessment |
|---|---|---|
Market Regime |
Accurate | Risk-Neutral regime at entry matched the setup's low-volatility character and supported early-stage advance behavior. |
Leadership Quality |
Accurate | Relative strength rank of 87 correctly signaled group leadership; the financial sector positioning was appropriately recognized. |
Fundamental Quality |
Accurate | The extreme EPS and revenue growth metrics paired with strong net margin passed the quality bar and showed up in a winning trade structure. |
Setup Structure |
Accurate | Stage 2 gate pass, MA20 proximity, RSI constructive, and volume dry-up were all correctly identified and validated by price action. |
Lifecycle Phase |
Partial | Base 3 identification was correct, but the thesis's own warning about early fatigue was not actively monitored during the hold; no journal entry recorded actual price behavior on closes. |
Capital Protection |
Accurate | Stop placement at $30.95 was tight and held; risk score of 8/24 reflected appropriate cushion relative to entry. |
Character Assessment |
Accurate | The stock behaved as a quality holding without erratic reversals; the characterization of elite fundamentals held water. |
Consider tightening the monitoring protocol for Base 3 structures in the Lifecycle Phase section. The thesis correctly flagged Base 3 as requiring active fatigue observation, but no mechanism was in place to log daily confirmation behavior (volume, close relative to MA20, RSI trajectory) during the hold. A lightweight daily log—even one line per day—would either validate the exit signal or surface evidence of breakout potential that target-based exits might otherwise obscure. This is especially relevant for high-quality, low-volatility setups where early exit can cost multiples.
The broader market was in Risk-Neutral regime at entry, which typically supports low-volatility, orderly advances in quality setups. Over the 14-day hold period (July 8–22, 2026), no major regime shift was recorded, and the financial sector did not face visible headwinds. The lack of earnings catalysts within the window and the steady climb to target suggest the trade benefited from a benign, steady-state market environment without sector-specific rotation or volatility spikes.